SPECIFIC PHARMA A/S: Financial statements 2021
CVR: 33161395
Source: annual report 2021, Danish Business Authority
01/02/2020 – 31/01/2021
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 139,630,000 and a net result of DKK 14,799,000 compared with DKK 8,237,000 the year before. That is an increase of 8.9% compared with the year before. The profit margin was 10.6%. Equity in the 2021 report amounted to DKK 88,820,000. The solvency ratio was 82.8%. The company had 21 employees in the financial year.
- Revenue
- DKK 139,630,000
- Gross Profit
- DKK 32,541,000
- Profit/Loss
- DKK 14,799,000
- Equity
- DKK 88,820,000
- Total Assets
- DKK 107,235,000
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
| 2020 | 128.2 mio. | 27 mio. | 8.2 mio. | 80.2 mio. | 16 |
| 2019 | 146.4 mio. | 25.3 mio. | 8.9 mio. | 78.6 mio. | 15 |
| 2018 | 145.7 mio. | 29.7 mio. | 14.8 mio. | 69.7 mio. | 12 |
| 2017 | 142.4 mio. | 41.9 mio. | 26.2 mio. | 74.6 mio. | 8 |
Official annual report
Find more companies like SPECIFIC PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.